CDK5 and prostate carcinoma: To investigate the levels of Cdk5-phosphorylated drebrin we used pS142-drebrin antibodies.4 This showed that pS142-drebrin is present in all prostate cancer cell lines examined and that the levels are proportional to the levels of drebrin (Figures 2a and b).